The ethical issues of genetic testing in children

View at publisher Summarise with VIRAT
Authors: Helen C. O’Neill, R Relton
Cited by: 0
References: 9

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Genetic diseases are a leading cause of infant and child mortality. Eighty per cent of rare diseases are genetic, and they collectively affect 4-8% of the population, causing a large healthcare resource burden. Diagnosis of genetic disorders can be challenging, but advancements in genetic sequencing have made testing for these diseases more accessible. Informed consent requires the sharing of significant information and understanding from the family. False-positive results, or secondary information which may be revealed by screening, are a considerable concern. The general consensus is that the most significant variants, for which preventive therapies are available, should be the focus of screening. The potential to build a lifetime genetic record for a child holds huge future potential, but this approach raises issues regarding confidentiality, data storage, and access to the data. An ethical framework for genetic screening in children is essential.

Fields of Study & Subjects

Ethics and Legal Issues in Pediatric Healthcare Medical and Health Sciences Research Ethics and bioethics in healthcare

Publication details

Journal / source
Oxford University Press eBooks
Pages
81–84
Publication date
26 March 2026
Language
EN
Document type
Book chapter